Barbara Shannon

Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease

Carlos Cruchaga, M. Barcikowska, R. Uitti, 2014, Neurobiology of Aging.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Stephanie D. Wilson, S. Ellias, J. Nutt, 2014, JAMA neurology.

A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study.

J. Nutt, C. Adler, L. Josephson, 2002, Archives of neurology.

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Jane S. Paulsen, Megan M. Romer, J. Jankovic, 2016, JAMA neurology.

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

R. Reilmann, K. Marder, J. Corey-Bloom, 2019, The Lancet Neurology.

Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families.

J. Jankovic, K. Marder, W. Weiner, 2003, Human molecular genetics.

Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study.

J. Jankovic, L. Seeberger, L. Raymond, 2008, Archives of neurology.